Should You Buy Canada Goose Holdings Inc. Ahead of Earnings?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) has seen tremendous growth in its first year on the TSX, but can investors expect that to continue?

| More on:

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) has been listed on the TSX for almost a year now, and the results have been encouraging. In less than a year, the stock price has doubled, and the company has continued to show incredible growth. Canada Goose will release its third-quarter results in early February, and investors may be wondering if now is a good time to buy.

Let’s take a closer look at how Canada Goose has done, where its value is today, and whether the stock is a good buy ahead of its upcoming earnings.

Growth has been strong, but can it last?

In its most recent quarter, sales were up more than 34%, and net income nearly doubled from a year ago. However, in two of the past three quarters, the company has finished in the red. In fiscal 2017, the company’s revenues broke through $400 million and were up 39% from 2016.

Over the past three years, sales have more than doubled and are on pace for another great year. Revenue in the trailing 12 months has totaled $460 million. Canada Goose has been averaging a profit margin of a little less than 9%.

The problem I see is that even though the company had a strong Q2, there are several warning flags for investors. Growing inventory and debt levels are not things that should be ignored by investors, and you only need to look as far as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) to see the problems that can occur when a company gets saddled with too much debt.

The retail world has been a tough one, and while Canada Goose is showing tremendous growth so far, it’s hard to envision a big market for $1,000 parkas and other high-priced clothing items.

Stock is not a value buy

At a book value of just over $1.6, Canada Goose is trading 27 times that amount. With limited earnings, the stock is also at a price-to-earnings multiple north of 100. Value investors will not have much attraction to this stock, and Canada Goose is only a good buy at the price if you see the growth continuing, which I’m skeptical of.

Should you buy before Q3?

The company’s upcoming earnings is its peak season, and a year ago sales totaled more than $209 million, which was a 63% increase from the previous quarter. A similar jump this year would send sales to over $280 million.

However, it’s this seasonality that also possesses a big risk. A warmer-than-normal winter could wreak havoc on the company’s financials. The company effectively has two off-peak quarters: those ending in March and June. Revenue during these quarters combined for less than $80 million this past year, less than half of Q2 totals.

Canada Goose is not a stock that I would consider buying when you consider its high valuation and limited market potential. While the stock may have generated significant returns already, that makes me concerned that there might not be much upside left at the current value.

There might be some decent returns that could be achieved in the short term, but this is not a stock that I’d suggest leaving in your portfolio for a long period of time.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Abstract technology background image with standing businessman
Tech Stocks

AI Spending Is Poised to Hit US$700 Billion in 2026: 2 Top Stocks to Buy to Capitalize on This Massive Number

These two Canadian stocks are well-positioned for the AI surge ahead.

Read more »

Top TSX Stocks

If I Could Only Buy and Hold a Single Stock, This Would Be It

Bank of Nova Scotia is a compelling buy-and-hold stock thanks to its stability, global reach, and reliable dividend income.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

2 Canadian AI Stocks Quietly Positioning for Big Gains

WELL Health and OpenText are two Canadian AI stocks quietly building serious competitive moats. Here is why both could be…

Read more »

Senior uses a laptop computer
Tech Stocks

A Year Later: 3 Canadian Stocks I Still Want in My TFSA

Three TFSA-friendly compounders still look like they’re executing a year later, even if none of them is truly “cheap.”

Read more »

man looks worried about something on his phone
Energy Stocks

This $34 Stock Could Be Your Ticket to Millionaire Status

Strong cash flow and expansion plans make this TSX stock hard to ignore.

Read more »

Colored pins on calendar showing a month
Dividend Stocks

2 TSX Stocks That Turn Dividends Into Reliable Monthly Paycheques

Given their solid underlying businesses, healthy growth prospects and high yields, these two TSX stocks can boost your passive income.

Read more »

Young Boy with Jet Pack Dreams of Flying
Investing

The Canadian Stocks I’d Consider First If I Had $2,000 to Invest Today

These Canadian stocks are benefitting from durable demand and structural growth drivers, and likely to generate consistent returns.

Read more »

gold prices rise and fall
Metals and Mining Stocks

2 Canadian Mining Stocks Worth Considering Right Now

Agnico Eagle is benefitting from strong gold prices, and Teck Resources has strong upside as copper prices momentum continues.

Read more »